Site icon Pharmawiki.in

PEBC – Canada Registered Pharmacist EXAM Question Paper with Answers PDF

PEBC Exam paper

Pharmacist Evaluating Examination Sample Questions are given here with answers. The questions are designed to test the knowledge of pharmacists and their ability to apply it in their daily practice. Generally, the exam is divided into two parts, namely a written part and a practical part. The written part consists of multiple choice questions which can be answered using different options provided by the question. On the other hand, the practical OSCE is Part 2 of the examination. The questions here provided are just for practice and based on previous paper or another similar one from the sample paper.

 

BIOMEDICAL SCIENCES

 

  1. pyrimidine
  2. purine
  3. pyrazine
  4. pteridine
  5. pyridine

 

  1. Pineal gland
  2. Thyroid gland
  3. Periaqueductal grey matter
  4. Reticular activating system
  5. Pituitary gland

 

  1. retinoic

 

  1. The enzyme responsible for initiating transcription is RNA
  2. The enzyme responsible for initiating transcription is DNA
  3. During transcription, the genetic information contained in the nucleotide sequence of tRNA is translated into a protein
  4. The process of transcription includes the splicing of
  5. Following initiation, the next stage of transcription is

 

  1. Escherichia coli
  2. Legionella pneumophila
  3. Staphylococcus aureus
  4. Streptococcus pneumoniae
  5. Chlamydophila pneumoniae

 

  1. Hepatic artery
  2. Hepatic portal vein
  3. Great saphenous vein
  4. Inferior vena cava
  5. Superior vena cava

 

  1. 5
  2. 10
  3. 15
  4. 20
  5. 25

 

  1. Chlamydophila pneumoniae
  2. Mycoplasma pneumoniae
  3. Haemophilus influenzae
  4. Streptococcus pneumoniae
  5. Pneumocystis jirovecii

 

  1. Gamma-aminobutyric acid
  2. Dopamine
  3. Glutamate
  4. Acetylcholine
  5. Glycine

 

  1. Reverse transcriptase
  2. DNA polymerase
  3. RNA polymerase
  4. Endonuclease
  5. Aminoacyl-tRNA synthetase

 

 

 

  1. blind
  2. macula

 

  1. Increased urine production
  2. Increased acetylcholine release
  3. Increased aldosterone secretion
  4. Increased diameter of systemic arterioles
  5. Increased erythropoietin production

 

  1. Calf muscles
  2. Deep back muscles
  3. Shoulder muscles
  4. Quadriceps femoris muscles
  5. Abdominal muscles

 

  1. Liver
  2. Pancreas
  3. Spleen
  4. Submandibular gland
  5. Appendix

 

  1. reduces immunization costs in
  2. enhances individual immunologic
  3. facilitates animal
  4. protects people who cannot be
  5. requires fewer booster

 

PHARMACEUTICAL SCIENCES

 

EXCEPT:

  1. there is minimal loss of activity in heat labile
  2. the liquid must be frozen to below the eutectic
  3. the solute usually forms an amorphous
  4. the eutectic temperature is the freezing point of the drug
  5. water is removed from the frozen mixture by

 

  1. selectively dilates renal and mesenteric vascular
  2. does not induce peripheral
  3. decreases the force of myocardial
  4. delays the atrioventricular (AV) conduction
  5. prolongs the QT interval on the

 

  1. is
  2. is protein
  3. is acidic but not protein
  4. has a small volume of
  5. has a large volume of

 

  1. 5 mg/L
  2. 7 mg/L
  3. 1 mg/L
  4. 4 mg/L
  5. 7 mg/L

 

21

Valproic acid is metabolized by aliphatic hydroxylation to the above two structures. The relationship between the two metabolites illustrates the concept of:

  1. conformational
  2. structural
  3. geometric
  4. optical

 

 

  1. Carbamazepine
  2. Clarithromycin
  3. Amiodarone
  4. Metronidazole
  5. Bosentan

 

Ethanol 10%

Propylene glycol 40%

Benzyl alcohol 1.5%

Water for Injection qs 100%

In the formulation given above, propylene glycol functions as a(n):

 

  1. Amount of preservative added
  2. Molecular weight of the drug
  3. Solubility of the emulsifier in water
  4. Particle size of the internal phase
  5. Type of suspending agent used

 

  1. stimulating adenosine
  2. binding to MHC Class II on B
  3. inhibiting B cell
  4. activating T cell
  5. binding CD80/86 on antigen-presenting

 

  1. affected by the extent of absorption
  2. affected by the rate of absorption
  3. affected by neither rate nor extent of
  4. affected by both rate and extent of
  5. the only significant

 

27

The above structures are related to one another as:

  1. positional (structural)

 

  1. 4
  2. 5
  3. 5.4 h.
  4. 5.8 h.
  5. 6 h.

 

  1. to mask the taste of the
  2. to mask the odor of the
  3. to improve the appearance of the
  4. to increase the drug’s release
  5. to protect the drug from stomach

 

  1. Deliquescence
  2. Efflorescence
  3. Hygroscopicity
  4. Polymorphism
  5. Condensation

 

 

  1. Diluents are fillers to add bulk to the
  2. Lubricants help the patient to swallow the tablet more
  3. Binding agents may be added dry or in
  4. Disintegrants draw water into the tablet causing it to
  5. Glidants promote the flow of materials during

 

  1. taste of the
  2. physical appearance of the
  3. pharmacokinetic parameters of the
  4. cost of the
  5. package size of the

 

 

  1. is extensively
  2. accumulates in patients with moderate renal failure
  3. undergoes significant entero-hepatic
  4. is not bound to plasma
  5. is concentrated in adipose

 

  1. A
  2. B
  3. C
  4. D
  5. E

 

  1. tyrosine kinase of Bcr-Abl.
  2. tyrosine kinase of HER-2.
  3. tyrosine kinase of
  4. histone
  5. serine/threonine kinase

 

  1. Furosemide
  2. Hydrochlorothiazide
  3. Spironolactone
  4. Acetazolamide
  5. Amiloride

 

  1. dry
  2. flushed
  3. delirium and restlessness.

 

  1. Combining with acetylcholine
  2. Potentiating the action of acetylcholinesterase
  3. Forming a very stable complex with acetylcholinesterase
  4. Reacting at the cholinergic receptor
  5. Preventing the release of acetylcholine from the nerve ending

 

  1. Nebivolol
  2. Metoprolol
  3. Acebutolol
  4. Nadolol
  5. Carvedilol

 

  1. Flu-like symptoms commonly occur at the start of
  2. T cells are stimulated and will initiate a host rejection
  3. Adalimumab is a murine-derived immunoglobulin monoclonal antibody
  4. Use of chimeric monoclonal antibodies is associated with increased
  5. Use of Fc fragments avoids raising an immune response against the FAB

 

  1. an
  2. a
  3. a
  4. a
  5. an

 

 

  1. Viruses can be introduced by
  2. Viruses can be generated by an infected production cell
  3. The most frequent source of virus introduction is the growth
  4. Viruses can be inactivated by physical or chemical treatment of the
  5. There is a trend toward using better-defined growth media in which serum levels are significantly reduced.

 

  1. Albumin
  2. Lysine
  3. Tween 20
  4. Saline
  5. Phosphate

 

 

  1. prolonged residence of the antibiotic in the
  2. post-antimicrobial
  3. enhanced tissue
  4. reduced renal
  5. higher peak-trough

 

  1. 100 mg
  2. 300 mg
  3. 500 mg
  4. 740 mg
  5. 900 mg

 

  1. Oral
  2. Rectal
  3. Ocular
  4. Pulmonary
  5. Transdermal

 

  1. Permeability of the drug
  2. Dissolution of the drug
  3. Strength of the drug
  4. Solubility of the drug
  5. Partitioning of the drug

 

  1. drug binding to plasma
  2. bile
  3. hepatic blood
  4. renal blood
  5. p-glycoprotein transport

 

  1. Most drugs can permeate the skin and enter the systemic
  2. Transdermal absorption achieves a fast onset of drug
  3. The skin is tolerant to most drugs and chemicals in transdermal delivery
  4. Transdermal administration produces minimal variations in drug
  5. Hair follicles are a determinant in limiting transdermal drug

 

and concentrations of both drugs were measured. A semilog plot of concentration vs. time is shown below. The concentration of Drug A is represented by the solid line and Drug B by the dashed line.

 

 

 

 

Which of the following statements is correct?

  1. The absorption rate constants for Drug A and Drug B can be estimated from the
  2. Drug B has a lower clearance than Drug
  3. Drug A has a larger distribution volume than Drug
  4. Drug B has a higher plasma protein binding than Drug
  5. The volume of distribution for Drug A can be estimated from the

 

  1. Clonidine
  2. Terazosin
  3. Mirtazapine
  4. Risperidone
  5. Venlafaxine

 

Dose                  Half-life

0.2 mg/kg           2 days

5 mg/kg            18 days

What is the reason for the dose-dependent t1/2? The biologic drug:

  1. eliminates primarily by the lymphatic system at lower
  2. eliminates primarily by the liver resulting in nonlinear
  3. eliminates by
  4. distributes rapidly to peripheral organs at lower
  5. exhibits target-mediated drug

 

  1. PCSK9
  2. lipoprotein
  3. vascular oxidative
  4. scavenger receptor
  5. HDL

 

  1. Dry heat
  2. Steam autoclave
  3. Ionizing radiation
  4. Ethylene oxide gas
  5. Filtration

 

  1. ELISA
  2. Quantitative PCR
  3. Peptide mapping
  4. SDS-polyacrylamide gel electrophoresis
  5. Amino acid sequencing

 

decreased risk of extrapyramidal side effects observed with some second generation antipsychotics relative to first generation antipsychotics?

  1. Serotonergic
  2. Histaminergic
  3. Muscarinic
  4. Noradrenergic
  5. Alpha-adrenergic

 

  1. Lactose
  2. Potato starch
  3. Croscarmellose
  4. Dicalcium phosphate
  5. Sodium lauryl sulfate

 

  1. Decreasing drug solubility
  2. Extracting oral mucosal lipids
  3. Disrupting saliva secretion
  4. Increasing drug particle size
  5. Prolonging oral retention

 

  1. Size
  2. Shape
  3. Hardness
  4. Coating
  5. Stability

 

PHARMACY PRACTICE – Clinical Sciences

 

  1. Sertraline
  2. Fluoxetine
  3. Duloxetine
  4. Escitalopram
  5. Desvenlafaxine

 

  1. Fluoroquinolones can cause blood glucose alterations in elderly patients who take oral antihyperglycemic
  2. Healthy women with acute uncomplicated cystitis should be treated for a minimum of 7 days with a fluoroquinolone.
  3. Therapeutic drug monitoring is recommended with prolonged fluoroquinolone therapy, to avoid ototoxicity.
  4. In the case of treatment failure, another fluoroquinolone should be tried before switching to a different antibiotic
  5. All fluoroquinolones have equal efficacy when used to treat patients with community-acquired pneumonia.

 

QUESTIONS 64 TO 65 INCLUSIVE REFER TO THE FOLLOWING:

SM is a 34 year old female who, while vacationing in Mexico, began prophylactic treatment for travellers’ diarrhea. Shortly thereafter she complained of a feeling of fullness in her ears, black stools and a black tongue. SM’s previous history includes an allergy to sulfonamides.

 

  1. Bismuth subsalicylate
  2. Cotrimoxazole (sulfamethoxazole/trimethoprim)
  3. Doxycycline
  4. Amoxicillin
  5. Loperamide

 

  1. Bacteroides fragilis.
  2. Escherichia coli.
  3. Clostridium difficile.
  4. Listeria monocytogenes.
  5. Pseudomonas aeruginosa.

 

 

************

 

  1. Ciprofloxacin
  2. Allopurinol
  3. Isotretinoin
  4. Ramipril
  5. Raloxifene

 

  1. Fill the prescription as written
  2. Refuse to fill the prescription as the antibiotic order is no longer current
  3. Indicate a need to contact the prescriber before filling the prescription at this time
  4. Fill the prescription for a quantity that is the ordered amount less three days’ supply
  5. Explain that, at this late date, antibiotic therapy will likely be ineffective for the child

 

  1. Oral metronidazole
  2. Intravenous metronidazole
  3. Oral cholestyramine
  4. Oral vancomycin
  5. Intravenous vancomycin

 

  1. Too high a dosage of atorvastatin
  2. Too high a dosage of zopiclone
  3. Need for cytoprotection with ibuprofen
  4. Drug interaction between atorvastatin and zopiclone
  5. Too low a dosage of levothyroxine

 

  1. To provide drug allergy information to the patient’s insurance
  2. To encourage the patient to fill future prescriptions at this
  3. To advertise relevant pharmacy products or services to appropriate
  4. To enhance continuity of patient care regardless of the
  5. To provide a record of cognitive services for insurance

 

 

QUESTIONS 71 TO 72 INCLUSIVE REFER TO THE FOLLOWING:

 

TK is a 63 year old male with chronic kidney disease (CrCl = 29 mL/min/1.73m2) and gout. He experienced his last gout attack about two months ago. Today his toe is extremely painful, hot, red, and swollen. At a walk-in clinic, he receives a prescription for naproxen 500 mg po bid for five days. TK’ s other current medication is pravastatin 20 mg po at bedtime.

 

  1. Naproxen is inferior to indomethacin for the treatment of acute
  2. The duration of naproxen treatment is too
  3. Naproxen should be avoided in patients taking
  4. Naproxen should be avoided in patients with renal
  5. The frequency of naproxen dosing is too

 

  1. limit fluid
  2. take medication on an empty
  3. use precautions to avoid
  4. report any skin rash or itching to the
  5. avoid dairy products or multivitamins within 2 hours of

**********

 

 

  1. Neuropathy
  2. Cardiotoxicity
  3. Neutropenia
  4. Emesis
  5. Nephrotoxicity

 

  1. enzyme
  2. mineral
  3. transporter
  4. vitamin

 

Aclidinium 400 mcg inhaler, one inhalation bid

Budesonide 200 mcg/formoterol 6 mcg Turbuhaler®, 2 inhalations bid Salbutamol 100 mcg MDI, 2 inhalations qid

Sitagliptin100 mg, one tablet po daily Metformin 500 mg, one tablet po tid

Venlafaxine ER 150 mg, one capsule po at bedtime

Which of the following drug therapy problems should be identified for this patient?

  1. Taking too high a dosage of aclidinium
  2. Taking too high a dosage of metformin
  3. Inappropriate dosing time for venlafaxine
  4. Drug interaction between sitagliptin and metformin
  5. Duplication of therapy with salbutamol and formoterol

 

  1. Alzheimer disease
  2. Systemic lupus erythematosus
  3. Osteoarthritis
  4. Parkinson disease
  5. Paget disease

 

  1. Cystitis
  2. Septicemia
  3. Urinary retention
  4. Pyelonephritis
  5. Asymptomatic bacteriuria

 

  1. strategies to minimize cardiac risk
  2. the facts on diabetes and its
  3. the role of blood glucose
  4. appropriate dietary
  5. the technique for the mixing of

 

  1. Urea 20% cream
  2. Tacrolimus 0.03% cream
  3. Pimecrolimus 1% cream
  4. Betamethasone dipropionate 0.05% ointment
  5. Clobetasone propionate 0.05% cream

 

  1. Low sputum pH
  2. Aspiration
  3. Thick, tenacious sputum
  4. Neutropenia
  5. Epiglottal closure

 

  1. After using sublingual nitroglycerin
  2. After eating a high-fat meal
  3. If receiving hemodialysis
  4. If taking testosterone supplementation
  5. For males over the age of 60 years

 

  1. Vitamin A
  2. Vitamin B12
  3. Vitamin C
  4. Vitamin D
  5. Vitamin K

 

  1. Prevent infection
  2. Prevent mortality
  3. Maintain quality of life
  4. Achieve endoscopic remission
  5. Limit the number of colectomies

 

  1. Increase escitalopram to 40 mg po once daily
  2. Add diazepam 5 mg po once daily to escitalopram
  3. Add aripiprazole 2 mg po once daily to escitalopram
  4. Stop escitalopram and start fluoxetine 20 mg po once daily
  5. Stop escitalopram and start venlafaxine XR 150 mg po once daily

 

PHARMACY PRACTICE – Professional Practice Skills Questions

 

  1. Reduction of medication errors
  2. Reduction of inventory pilferage
  3. Reduction of preventable adverse effects
  4. Assessment of patient adherence to therapy
  5. Enhanced accuracy of patient allergy information

 

  1. Canadian Agency for Drugs and Technologies in Health
  2. Health Canada
  3. Institute for Safe Medication Practices
  4. Canadian Patient Safety Institute
  5. Canadian Institute for Health Information

 

 

  1. with or in
  2. extracellular
  3. exact
  4. soluble in
  5. out of

 

  1. 12.5% w/w.
  2. 16.7% w/w.
  3. 20% w/w.
  4. 23.8% w/w.
  5. 25% w/w.

 

  1. Adhering to guidelines for cold chain management
  2. Maintaining a regular cleaning schedule for dispensary surfaces
  3. Cleaning counting trays and automated counting machines regularly
  4. Using TALLman lettering on all prescription labels
  5. Regulating the pharmacy’s indoor climate where medications are stored

 

  1. provides a compilation of clinical practice guidelines for health care
  2. provides systematic reviews that are based solely on evidence from primary
  3. has an emphasis on providing patient/consumer information on a wide variety of health
  4. is limited by its availability only through paid subscription by health care
  5. is limited by a lag to publication and updating of patient therapy-related

 

  1. If the sumatriptan does not relieve the headache within four hours, ergotamine may be
  2. If no relief is achieved in two hours, sumatriptan may be
  3. If the headache is relieved but another headache occurs eight hours later, sumatriptan may be used for the second
  4. The maximum dosage in any 24-hour period is six
  5. If relief is not achieved, no other medication can be used for 24

 

  1. Felodipine
  2. Amlodipine
  3. Levetiracetam
  4. Divalproex
  5. Gabapentin

 

  1. 5 mL
  2. 15 mL
  3. 25 mL
  4. 5 mL
  5. 50 mL

 

  1. Increase in fill quantity for each prescription refill
  2. Reduced number of prescriptions filled per month
  3. Increase in number of nonprescription medications used
  4. Reduced number of prescription refill dates per month
  5. Prescription refill dates closer to expected fill intervals

 

Sig: gtt. i o.d. bid

On the prescription label the instructions to the patient should read:

  1. apply one drop into both eyes twice
  2. instil one drop into the left eye twice
  3. instil one drop into the right eye twice
  4. shake well and instil one drop into the left eye twice
  5. shake well and instil one drop into the right ear twice

 

 

  1. Insulin NPH 10 units subcut at bedtime
  2. Oxycodone CR 40 mg po q12h
  3. Gliclazide 80 mg po bid
  4. MTX 7.5 mg po weekly
  5. Levothyroxine 88 mcg po daily

 

  1. It requires a written order from an authorized
  2. It is an example of a legally exempted codeine
  3. Sale for self-medication use must involve a
  4. It is regulated under the Benzodiazepines and Other Targeted Substances
  5. Authorized prescribers include

 

  1. 20 mL
  2. 60 mL
  3. 80 mL
  4. 100 mL
  5. 120 mL

 

  1. magnesium

 

  1. Zithromax Z-Pak® (azithromycin 250 mg), 2 tabs po on day 1 and 1 tab po on days 2-5.
  2. Flonase® (fluticasone) 100 mcg spray, 1 or 2 sprays in each nostril bid x 1 bottle
  3. Actonel® (risedronate), 35 mg po once weekly x 12 tabs
  4. Cozaar® (losartan), 50 mg po bid x 1 month
  5. Zocor® (simvastatin), 1 tab po hs for 3 months

 

  1. Confidentiality
  2. Nonmaleficence
  3. Justice
  4. Veracity
  5. Autonomy

 

 

  1. A type I error frequently occurs when sample sizes are
  2. A type II error is more serious than a type I
  3. Small p-values suggest that the null hypothesis is likely to be
  4. The larger the p-value, the more likely the null hypothesis is
  5. P-value is the probability of wrongly rejecting the null hypothesis if it is in fact

 

 

  1. 10%.
  2. 15%.
  3. 25%.
  4. 40%.
  5. 50%.

 

  1. 15.
  2. 20.
  3. 150.
  4. 200.
  5. 2000.

 

  1. the statistical conclusion is that there is a difference between the two treatment regimens when a difference does not actually
  2. the statistical conclusion is that there is no difference between the two treatment regimens when a difference actually does
  3. the p level is > 05.
  4. the drug treatments studied are not appropriate comparators for the
  5. the exclusion criteria are too

 

  1. The study size was too small to assess
  2. The patients did not achieve guideline targets for
  3. Blood pressure is a surrogate
  4. Long term safety and efficacy were not
  5. Placebo is not an appropriate

 

  1. Vitamins and minerals
  2. Pharmaceuticals
  3. Controlled Drugs
  4. Benzodiazepines and Targeted Substances
  5. Narcotic Preparations

 

  1. Provision of patient-specific counselling by pharmacists
  2. Lack of adequate education and training of pharmacists
  3. Lack of pharmacist follow up in assessing patient outcomes
  4. Increased patient demands for more frequent medical appointments
  5. Interruption of physician workflow due to pharmacist communications

 

  1. Vaccines exposed to temperatures above the recommended range can have an increase in potency and should not be administered to any
  2. Vaccines exposed to temperatures below the recommended range should be labelled “do not use” and kept at room temperature until their integrity is
  3. Inactivated vaccines are more likely than live attenuated vaccines to have a shortened half-life when exposed to high temperatures (up to 37º C).
  4. Diluents of vaccines that have been frozen can be used as they do not contain any active ingredients.
  5. Vaccines containing an aluminum adjuvant experience a permanent loss of potency when subjected to

 

 

Questions from BEHAVIOURAL, SOCIAL AND ADMINISTRATIVE PHARMACY SCIENCES

 

 

 

Drug Cost/Day Dosing Frequency Treatment Duration (days)
A $2.50 qid 14
B $2.25 once daily 14
C $5.00 bid 7
D $2.25 bid 7
E $2.25 qid 7

The most appropriate choice for the hospital is:

  1. Drug
  2. Drug
  3. Drug
  4. Drug
  5. Drug

 

  1. Balance sheet
  2. Statement of investments
  3. Statement of changes in financial position
  4. Income statement
  5. Statement of equity

 

  1. the Canada Health
  2. individual provinces and
  3. Health Canada’s Health Environment and Consumer Safety
  4. Canadian Agency for Drugs and Technologies in Health
  5. Public Health Agency of

 

  1. Purchasing narcotic drugs
  2. Selecting clinical decision software for the dispensary computer
  3. Coordinating staff scheduling
  4. Supervising pharmacy technicians
  5. Determining workflow for the pharmacy’s professional services

 

  1. educating on improved prescription
  2. advising on optimal patient interviewing
  3. recommending strategies to avoid medication
  4. providing current information on best prescribing
  5. promoting the use of physician samples given to

 

  1. audit the financial performance of provincial pharmacy licensing
  2. promote harmonization of pharmacy practice standards across
  3. establish a unified lobby voice for pharmacists from all types of practice
  4. provide mechanisms for the public to file complaints about pharmacy care
  5. accredit the pharmacy programs at Canadian universities

 

  1. source of funding for conducting the pharmacoeconomic
  2. approach the researcher takes to analyze the research
  3. approach the researcher uses to limit confounding
  4. stakeholder whose interest is most represented in the study’s
  5. method used to facilitate communication of the study results in a journal

 

  1. Assigning the responsibility of ordering and receiving of inventory to one
  2. Implementing an employee bag check program at the end of
  3. Hiring a uniformed security guard to monitor the pharmacy
  4. Offering incentives such as employee discounts on
  5. Installing mirrors and security cameras strategically throughout the

 

  1. Women
  2. The elderly population
  3. Children with asthma
  4. High-income earners
  5. Parents of young children

 

  1. The specificity of the test is lower in Community
  2. The specificity of the test is higher in Community
  3. The prevalence of disease is lower in Community
  4. The prevalence of disease is higher in Community
  5. It is not possible to explain the difference between Community A and

 

  1. provincial
  2. provincial drug
  3. Canadian Medical
  4. federal
  5. Royal College of Physicians and Surgeons of

 

  1. cost-benefit
  2. cost-minimization
  3. cost-effectiveness
  4. cost-efficacy analysis.
  5. cost-utility

 

  1. case-control
  2. retrospective cohort
  3. randomized control
  4. case-crossover
  5. cross-sectional

 

  1. reduces the amount of time that pharmacists must spend with
  2. generates a stream of high revenue from an identifiable customer
  3. helps the pharmacy staff to greet customers by their first
  4. protects the pharmacy manager from liability claims arising from dispensing
  5. is costly to attract new

There are few missing parts. Pls Download the PDF of Canada Registered Pharmacist Exam Question Paper

Canada Pharmacist Exam Question and Answers

Answers to above Questions

 

1. (d) 26. (d) 51. (c) 76. (e) 101. (b)
2. (c) 27. (c) 52. (e) 77. (b) 102. (e)
3. (a) 28. (c) 53. (c) 78. (e) 103. (e)
4. (a) 29. (d) 54. (e) 79. (e) 104. (e)
5. (e) 30. (b) 55. (c) 80. (b) 105. (d)
6. (b) 31. (b) 56. (d) 81. (e) 106. (e)
7. (a) 32. (c) 57. (d) 82. (b) 107. (b)
8. (d) 33. (a) 58. (c) 83. (c) 108. (d)
9. (a) 34. (c) 59. (e) 84. (d) 109. (c)
10. (a) 35. (a) 60. (b) 85. (c) 110. (e)
11. (c) 36. (d) 61. (c) 86. (b) 111. (e)
12. (a) 37. (e) 62. (a) 87. (b) 112. (d)
13. (c) 38. (c) 63. (a) 88. (a) 113. (d)
14. (a) 39. (a) 64. (a) 89. (a) 114. (a)
15. (c) 40. (a) 65. (b) 90. (b) 115. (c)
16. (d) 41. (a) 66. (c) 91. (d) 116. (d)
17. (d) 42. (c) 67. (a) 92. (c) 117. (b)
18. (a) 43. (c) 68. (d) 93. (c) 118. (d)
19. (a) 44. (c) 69. (c) 94. (a) 119. (b)
20. (b) 45. (b) 70. (d) 95. (a) 120. (c)
21. (b) 46. (b) 71. (d) 96. (e) 121. (d)
22. (a) 47. (d) 72. (d) 97. (c) 122. (a)
23. (c) 48. (d) 73. (e) 98. (d) 123. (d)
24. (d) 49. (c) 74. (c) 99. (a) 124. (d)
25. (e) 50. (a) 75. (b) 100.(e) 125. (e)

 

Exit mobile version